Rekvina Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE092O01028
  • NSEID:
  • BSEID: 526075
INR
22.30
0.42 (1.92%)
BSENSE

Feb 13

BSE+NSE Vol: 3.71 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 576337,
    "name": "Rekvina Labs",
    "stock_name": "Rekvina Labs",
    "full_name": "Rekvina Labs Ltd",
    "name_url": "stocks-analysis/rekvina-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "22.30",
    "chg": 0.42,
    "chgp": "1.92%",
    "dir": 1,
    "prev_price": "21.88",
    "mcapval": "13.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526075,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE092O01028",
    "curr_date": "Feb 13",
    "curr_time": "",
    "bse_nse_vol": "3.71 k",
    "exc_status": "Active",
    "traded_date": "Feb 13, 2026",
    "traded_date_str": "2026 02 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/rekvina-labs-576337-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High of Rs.22.31 on 13 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-of-rs2231-on-13-feb-2026-3837329",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3837329.png",
        "date": "2026-02-13 10:48:16",
        "description": "Rekvina Labs Ltd has reached a significant milestone by hitting a new 52-week high of Rs.22.31 today, marking a remarkable rally that has seen the stock gain over 200% in the past 21 trading sessions. This surge underscores a strong momentum in the stock’s price action, outperforming its sector and maintaining a consistent upward trajectory across multiple moving averages."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High at Rs.21.88",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-at-rs2188-3835036",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3835036.png",
        "date": "2026-02-12 10:41:29",
        "description": "Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.21.88, marking a significant milestone in its stock performance. This new peak reflects a sustained rally that has seen the stock deliver remarkable returns over the past three weeks, outpacing sector benchmarks despite broader market headwinds."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High of Rs.21.46 on 11 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-of-rs2146-on-11-feb-2026-3832392",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3832392.png",
        "date": "2026-02-11 09:44:10",
        "description": "Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.21.46, reflecting a remarkable rally that has seen the stock gain over 200% in the past 20 trading sessions. This milestone underscores the stock’s robust momentum amid a mixed broader market environment."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High of Rs.20.44 on 10 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-of-rs2044-on-10-feb-2026-3831084",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3831084.png",
        "date": "2026-02-10 11:12:09",
        "description": "Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.20.44, marking a significant milestone in its recent market performance. This new peak reflects sustained momentum, with the stock demonstrating robust gains over the past several weeks and outperforming its sector peers."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High at Rs.19.47",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-at-rs1947-3828205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3828205.png",
        "date": "2026-02-09 09:47:21",
        "description": "Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.19.47, reflecting a remarkable rally that has seen the stock gain 175% over the past 18 consecutive trading days. This milestone underscores the stock’s robust momentum and its outperformance relative to the broader sector and market indices."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High of Rs.18.55 on 6 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-of-rs1855-on-6-feb-2026-3824332",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3824332.png",
        "date": "2026-02-06 11:18:21",
        "description": "Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.18.55, marking a significant milestone in its recent trading performance. The stock’s sustained momentum has been evident through a remarkable 17-day consecutive gain, delivering a total return of 162.01% during this period."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High of Rs.17.67 on 5 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-of-rs1767-on-5-feb-2026-3822002",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3822002.png",
        "date": "2026-02-05 09:42:34",
        "description": "Rekvina Labs Ltd has reached a significant milestone by hitting a new 52-week high of Rs.17.67 today, marking a remarkable rally that has seen the stock surge over 149% in the past 16 trading sessions."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High at Rs.16.83",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-at-rs1683-3820488",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3820488.png",
        "date": "2026-02-04 10:17:26",
        "description": "Rekvina Labs Ltd has surged to a fresh 52-week high of Rs.16.83, marking a significant milestone in its stock performance. This new peak reflects a sustained upward momentum, with the stock outperforming its sector and demonstrating robust gains over the past month."
      },
      {
        "title": "Rekvina Labs Ltd Hits New 52-Week High of Rs.16.03 on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rekvina-labs-ltd-hits-new-52-week-high-of-rs1603-on-3-feb-2026-3818302",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/RekvinaLabsLtd_priceRelatedfactors_3818302.png",
        "date": "2026-02-03 10:38:45",
        "description": "Rekvina Labs Ltd achieved a significant milestone on 3 Feb 2026, reaching a new 52-week high of Rs.16.03. This marks a notable surge in the stock’s momentum, reflecting a sustained rally over the past fortnight that has propelled the share price to levels unseen in the last year."
      }
    ],
    "total": 22,
    "sid": "576337",
    "stock_news_url": "https://www.marketsmojo.com/news/rekvina-labs-576337"
  },
  "announcements": [
    {
      "caption": "Financial Results For The Quarter And Nine Months Ended On 31St December 2025.",
      "datetime": "09-Feb-2026",
      "details": "Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulation 2015 we hereby inform you that the Board of Directors of the Company at its meeting held on 06th February 2026 has inter-alia adopted and approved. 1. Financial Results for the Quarter and Nine Month ended on 31st December 2025. 2. Limited Review Report by Statutory Auditor of the Company on Standalone in-audited Financial Results for the Nine Month & Quarter ended on 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 06Th February 2026",
      "datetime": "06-Feb-2026",
      "details": "Dear Sir/Madam Pursuant to Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulations 2015 we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 6th February 2026 has inter-alia adopted and approved 1) The Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December 2025. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December 2025. The meeting of the Board of Directors commenced at 05:00 P.M. and concluded at 05:32 P.M. This is for your information and record Thanking you For Rekvina Laboratories Limited",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "29-Jan-2026",
      "details": "Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 we hereby inform you that the Board of Directors of the Company at its meeting held on 29th January 2026 have considered and approve appointment of Mr. Jay Chintan Patel as an Additional Non-Executive Independent Director.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Rekvina Labs Ltd has announced <strong>5:10</strong> stock split, ex-date: 30 Apr 14",
          "dt": "2014-04-30",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Financial Results For The Quarter And Nine Months Ended On 31St December 2025.

09-Feb-2026 | Source : BSE

Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulation 2015 we hereby inform you that the Board of Directors of the Company at its meeting held on 06th February 2026 has inter-alia adopted and approved. 1. Financial Results for the Quarter and Nine Month ended on 31st December 2025. 2. Limited Review Report by Statutory Auditor of the Company on Standalone in-audited Financial Results for the Nine Month & Quarter ended on 31st December 2025.

Board Meeting Outcome for Outcome Of The Board Meeting Held On 06Th February 2026

06-Feb-2026 | Source : BSE

Dear Sir/Madam Pursuant to Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulations 2015 we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 6th February 2026 has inter-alia adopted and approved 1) The Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December 2025. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Nine months ended on 31st December 2025. The meeting of the Board of Directors commenced at 05:00 P.M. and concluded at 05:32 P.M. This is for your information and record Thanking you For Rekvina Laboratories Limited

Announcement under Regulation 30 (LODR)-Change in Directorate

29-Jan-2026 | Source : BSE

Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 we hereby inform you that the Board of Directors of the Company at its meeting held on 29th January 2026 have considered and approve appointment of Mr. Jay Chintan Patel as an Additional Non-Executive Independent Director.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Rekvina Labs Ltd has announced 5:10 stock split, ex-date: 30 Apr 14

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available